Decades of research and technological advancements are enabling scientists to more fully understand how tumors proliferate, metastasize, and evolve. For example, researchers can now characterize tumors through comprehensive profiling to identify and develop targeted therapeutic interventions for each patient. Patient-derived xenograft (PDX) models are rapidly taking the place of traditional cell line approaches to better …